Who is sponsoring NCT01580943?

NCT01580943 is sponsored by Universidade do Porto.

What condition does NCT01580943 study?

NCT01580943 studies Dental Plaque.

What drugs are being tested in NCT01580943?

Interventions: Chlorhexidine, Chlorhexidine.

What is the status of NCT01580943?

NCT01580943 is currently COMPLETED.

Last reviewed 2012-04-20 · How we verify

Efficacy of Two Commercially Available Chlorhexidine Mouthrinses Non-alcohol Base - a Randomized Clinical Trial

NCT01580943 Phase 1/Phase 2 COMPLETED

The purpose of this study was to compare the antiplaque efficacy of a 0,12% chlorhexidine and 0,05% cetyl-pyridinium chloride mouth rinse (Perio-aid®) with a 0,2% chlorhexidine non-alcohol base mouth rinse (Corsodyl Care®).

Details

Lead sponsor	Universidade do Porto
Phase	Phase 1/Phase 2
Status	COMPLETED
Enrolment	50
Start date	2011-10
Completion	2012-03

Conditions

Dental Plaque

Interventions

Chlorhexidine
Chlorhexidine

Primary outcomes

antiplaque efficacy — 72 hours
antiplaque efficacy of two chlorhexidine mouth rinses: 0,12% chlorhexidine with 0,05% cetyl-pyridinium chloride mouth rinse (Perio-aid®) and a 0,2% chlorhexidine alcohol free mouth rinse (Corsodyl Care®) At baseline, all participants received a through supragingival dental prophylaxis to remove all stain, calculus and plaque. After 72h all participants were disclosed with a 1% erythrosine solution and the plaque in both groups was recorded at six sites per tooth on a 5-point scale using the Quigley \& Hein (1962) plaque index as modified by Turesky et al. (1970).

Countries

Portugal